Temporal Trends in and Associations With Nonsteroidal Anti‐inflammatory Drug Prescription in Adult and Pediatric Patients With Inflammatory Bowel Disease
Arthritis Care & Research · 2025
DOI: 10.1002/acr.25650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von Adam S Mayer und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Pennsylvania, Philadelphia. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Inflammatory Bowel Diseases, Practice Patterns, Physicians', Drug Prescriptions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, Spondyloarthritis Research and Treatment Network, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Abstract (Originalsprache)
Objective
Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against nonsteroidal anti‐inflammatory drug (NSAID) use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal trends in prescription NSAID and opioid use for patients with IBD and factors associated with NSAID fill trends.
Methods
This retrospective cohort study of adult and pediatric IBD patients used administrative claims data from 2000 to 2022. Prescription NSAID and opioid fills per calendar year were assessed. Wilcoxon‐Cuzick test of trend and generalized estimating equation models evaluated NSAID and opioid fill trends and assessed characteristics associated with NSAID use.
Results
Among the 361,025 IBD patients, there was a significant decreasing trend in the proportion prescribed NSAIDs over time ( P < 0.01). Fill rates of NSAIDs were markedly lower than opioids across the study period despite an increase in musculoskeletal pain codes. In the multivariable model, opioid prescription (odds ratio [OR] 2.13, 95% confidence interval [CI] 2.11–2.15), a diagnostic code for osteoarthritis (OR 1.57, 95% CI 1.55–1.59), or unspecified joint pain (OR 1.54, 95% CI 1.52–1.56) had strong independent associations with NSAID fill, whereas an age
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Pennsylvania, Philadelphia.
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
ORCID-Profile: Adam S Mayer, Michael D George, Pamela F Weiss
Förderung
- NIAMS NIH HHS
- Spondyloarthritis Research and Treatment Network
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Mayer, A. S., Xiao, R., Grossman, A., Bewtra, M., George, M. D., & Weiss, P. F. (2025). Temporal Trends in and Associations With Nonsteroidal Anti‐inflammatory Drug Prescription in Adult and Pediatric Patients With Inflammatory Bowel Disease. Arthritis Care & Research. https://doi.org/10.1002/acr.25650
Vancouver
Mayer AS, Xiao R, Grossman A, Bewtra M, George MD, Weiss PF. Temporal Trends in and Associations With Nonsteroidal Anti‐inflammatory Drug Prescription in Adult and Pediatric Patients With Inflammatory Bowel Disease. Arthritis Care & Research. 2025. doi:10.1002/acr.25650
BibTeX
@article{Mayer2025,
author = {Mayer, Adam S and Xiao, Rui and Grossman, Andrew and Bewtra, Meenakshi and George, Michael D and Weiss, Pamela F},
title = {Temporal Trends in and Associations With Nonsteroidal Anti‐inflammatory Drug Prescription in Adult and Pediatric Patients With Inflammatory Bowel Disease},
journal = {Arthritis Care & Research},
year = {2025},
doi = {10.1002/acr.25650}
}
EUVIMED